Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)

Shanghai No.1 Pharmacy Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,906	1,864	1,767	2,617	1,342	1,533
Other Revenue	51.35	51.35	52.23	38.5	56.25	53.79
Revenue	1,957	1,915	1,820	2,656	1,398	1,587
Revenue Growth (YoY)	7.38%	5.26%	-31.49%	89.94%	-11.89%	27.65%
Cost of Revenue	1,636	1,598	1,474	2,116	1,153	1,310
Gross Profit	321.48	317.2	345.21	540.36	244.86	276.82
Selling, General & Admin	322.57	318.56	315.85	307.58	230.69	227.8
Other Operating Expenses	6.51	5.88	8.36	9.53	4.71	4.96
Operating Expenses	309.91	305.27	333.8	333.73	235.93	233.83
Operating Income	11.57	11.93	11.41	206.63	8.94	42.99
Interest Expense	-6.31	-6.05	-7.59	-14.12	-3.15	-1.68
Interest & Investment Income	33.65	33.86	25.31	17.89	24.23	20.23
Currency Exchange Gain (Loss)	-0.18	-0.18	0.19	0.05	-	-
Other Non Operating Income (Expenses)	-36.28	3.42	-3.4	-3.94	0.26	-0.23
EBT Excluding Unusual Items	2.45	42.98	25.92	206.51	30.27	61.31
Gain (Loss) on Sale of Investments	0.38	0.38	12.14	0.29	-	-
Gain (Loss) on Sale of Assets	167.89	168.89	64.73	-0.07	1.23	0.07
Asset Writedown	-4.99	-4.99	-4.69	-19.99	-	-0.22
Other Unusual Items	9.02	9.02	19.41	3.79	33.75	29.49
Pretax Income	174.75	216.27	117.51	190.52	65.24	90.66
Income Tax Expense	42.38	52.66	28.24	46.96	15.82	22.11
Earnings From Continuing Operations	132.37	163.62	89.28	143.56	49.42	68.54
Minority Interest in Earnings	-0.62	-0.55	-	-	-	-
Net Income	131.75	163.06	89.28	143.56	49.42	68.54
Net Income to Common	131.75	163.06	89.28	143.56	49.42	68.54
Net Income Growth	37.64%	82.65%	-37.81%	190.49%	-27.90%	29.10%
Shares Outstanding (Basic)	223	223	223	224	225	221
Shares Outstanding (Diluted)	223	223	223	224	225	221
Shares Change (YoY)	0.14%	0.08%	-0.50%	-0.14%	1.60%	-0.05%
EPS (Basic)	0.59	0.73	0.40	0.64	0.22	0.31
EPS (Diluted)	0.59	0.73	0.40	0.64	0.22	0.31
EPS Growth	37.45%	82.50%	-37.50%	190.91%	-29.03%	29.17%
Free Cash Flow	18.56	-2.91	44.61	120.94	23.92	72.01
Free Cash Flow Per Share	0.08	-0.01	0.20	0.54	0.11	0.33
Dividend Per Share	0.220	0.220	0.125	0.195	0.070	0.095
Dividend Growth	76.00%	76.00%	-35.90%	178.57%	-26.32%	26.67%
Gross Margin	16.43%	16.56%	18.97%	20.34%	17.51%	17.44%
Operating Margin	0.59%	0.62%	0.63%	7.78%	0.64%	2.71%
Profit Margin	6.73%	8.51%	4.91%	5.41%	3.53%	4.32%
Free Cash Flow Margin	0.95%	-0.15%	2.45%	4.55%	1.71%	4.54%
EBITDA	17.8	18.38	18.79	214.25	16.71	51.35
EBITDA Margin	0.91%	0.96%	1.03%	8.07%	1.20%	3.24%
D&A For EBITDA	6.23	6.46	7.38	7.62	7.77	8.36
EBIT	11.57	11.93	11.41	206.63	8.94	42.99
EBIT Margin	0.59%	0.62%	0.63%	7.78%	0.64%	2.71%
Effective Tax Rate	24.25%	24.35%	24.03%	24.65%	24.25%	24.39%
Revenue as Reported	1,957	1,915	1,820	2,656	1,398	1,587
Advertising Expenses	-	6.11	6.6	4.75	2.99	4.93

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.